ArticleCancer management and research2022

Transformation from Small Cell to Squamous Cell Carcinoma in a Thymic Carcinoma Patient with a Durable Response to Anlotinib: A Case Report.

Wenru Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.